Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MGEN

Miragen Therapeutics

$3.27

-0.17 (-4.94%)

16:26
12/05/18
12/05
16:26
12/05/18
16:26
Hot Stocks
Miragen Therapeutics says Booth steps down as Chairman, replaced by Hatfield »

miRagen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGEN

Miragen Therapeutics

$3.48

-0.04 (-1.14%)

18:40
12/02/18
12/02
18:40
12/02/18
18:40
Hot Stocks
Miragen Therapeutics announces data from Phase 1 Cobomarsen trial »

Miragen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

Over a month ago
MGEN

Miragen Therapeutics

$4.36

-0.025 (-0.57%)

16:09
11/07/18
11/07
16:09
11/07/18
16:09
Earnings
Miragen Therapeutics reports Q3 EPS (29c), consensus (32c) »

Reports Q3 revenue $944K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 01

    Dec

MGEN

Miragen Therapeutics

$5.58

0.01 (0.18%)

07:09
10/01/18
10/01
07:09
10/01/18
07:09
Hot Stocks
Miragen Therapeutics: Remlarsen decreated corneal scarring in trial »

miRagen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
MGEN

Miragen Therapeutics

$6.25

-0.11 (-1.73%)

16:28
08/07/18
08/07
16:28
08/07/18
16:28
Earnings
Miragen Therapeutics reports Q2 EPS (29c), consensus (29c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

  • 04

    Sep

MGEN

Miragen Therapeutics

$6.40

-0.03 (-0.47%)

07:07
08/06/18
08/06
07:07
08/06/18
07:07
Hot Stocks
Miragen Therapeutics, LLS enter agreement to support development of cobomarsen »

miRagen Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

MGEN

Miragen Therapeutics

$6.87

-0.08 (-1.15%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Miragen Therapeutics management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

MGEN

Miragen Therapeutics

$7.34

0.24 (3.38%)

08:14
07/16/18
07/16
08:14
07/16/18
08:14
Conference/Events
Miragen Therapeutics management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

MGEN

Miragen Therapeutics

$7.57

0.24 (3.27%)

07:01
07/10/18
07/10
07:01
07/10/18
07:01
Hot Stocks
Miragen Therapeutics initiates Phase 2 clinical trial of MRG-201 »

miRagen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

MGEN

Miragen Therapeutics

$7.33

0.02 (0.27%)

08:06
07/09/18
07/09
08:06
07/09/18
08:06
Recommendations
Miragen Therapeutics analyst commentary at Oppenheimer »

Miragen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.